Related Experiment Video

Updated: Jun 6, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

Using nonlinear model predictive control to find optimal therapeutic strategies to modulate inflammation

Judy Day1, Jonathan Rubin, Gilles Clermont

  • 1Mathematical Biosciences Institute, The Ohio State University, 1735 Neil Ave, 377 Jennings Hall, Columbus, OH 43210, United States. judyday@gmail.com

Mathematical Biosciences and Engineering : MBE
|November 17, 2010
PubMed

Insights

Nonlinear model predictive control (NMPC) optimizes treatments for critically ill patients by personalizing inflammatory response strategies. This computational approach shows promise for improving outcomes in intensive care settings.

Area of Science:

  • Critical care medicine
  • Computational biology
  • Systems immunology

Background:

  • Modulating the inflammatory response is crucial for treating critically ill patients.
  • Computational models aim to understand systemic inflammation dynamics.
  • Translating computational findings into clinical practice requires identifying specific therapeutic targets.

Purpose of the Study:

  • To implement a nonlinear model predictive control (NMPC) algorithm for personalized treatment strategies.
  • To utilize a reduced computational model of acute inflammatory response to severe infection.
  • To identify patient-specific immuno-modulatory approaches for intensive care.

Main Methods:

  • Developed and applied a nonlinear model predictive control (NMPC) algorithm.
  • Used a reduced computational model simulating acute inflammatory response.
  • Incorporated simulated observations of clinically accessible inflammatory mediators.

Main Results:

  • NMPC successfully identified patient-specific therapeutic strategies.
  • Simulated NMPC strategies outperformed standardized therapies.
  • NMPC-derived strategies were superior even to those from general optimization routines.

Conclusions:

  • Computational modeling combined with NMPC can suggest novel immuno-modulatory strategies.
  • This approach holds practical utility for treating intensive care patients.
  • Personalized, model-based interventions show potential for improved clinical outcomes.

More Related Videos

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses06:43

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses

Published on: March 29, 2017

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...